BUCHANG PHARMA(SH:603858) Ge Long Hui A P P·2025-11-17 10:00Core Viewpoint - The company, Buchang Pharma, is expanding its business through a joint investment with several partners to establish a new company, enhancing its research capabilities and market competitiveness [1] Group 1: Investment and Partnership - Zhejiang Huapai, a subsidiary of Buchang Pharma, plans to invest in a new company alongside Hefei Keyinou Biotechnology Co., Jiangsu Industrial Technology Research Institute, and Hefei Kaisaisi Enterprise Management Partnership [1] - The registered capital of the joint venture is 2 million yuan, with Zhejiang Huapai contributing 222,200 yuan [1] Group 2: Strategic Development - The collaboration aims to leverage the strengths of each party, fostering stable partnerships and strategic alliances [1] - This investment aligns with national macro strategies and industry directions, supporting the company's strategic development needs [1] - The project is expected to enhance the research capabilities of both the company and Zhejiang Huapai, laying a solid foundation for future growth [1]